GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Respiri Ltd (ASX:RSH) » Definitions » Cash Flow for Lease Financing

Respiri (ASX:RSH) Cash Flow for Lease Financing : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Respiri Cash Flow for Lease Financing?

Respiri's Cash Flow for Lease Financing for the six months ended in Dec. 2023 was A$0.00 Mil. Respiri's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Compared with last quarter (A$0.00 Mil in Jun. 2023 ), Respiri's Cash Flow for Lease Financing remained the same in Dec. 2023 (A$0.00 Mil).

Respiri Cash Flow for Lease Financing Historical Data

The historical data trend for Respiri's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Respiri Cash Flow for Lease Financing Chart

Respiri Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Respiri Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Respiri Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Respiri Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Respiri's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Respiri (ASX:RSH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Respiri Ltd (ASX:RSH) » Definitions » Cash Flow for Lease Financing
Comparable Companies
ASX:UBI ASX:SOM ASX:CMP ASX:LBT ASX:CSX ASX:COV ASX:MX1 ASX:AT1 ASX:CVB ASX:CDX ABT SYK BSX MDT XTER:SHL EW SZSE:300760 DXCM ZBH ALGN
Traded in Other Exchanges
RSHUF:USA
Address
432 St Kilda Road, Level 9, Melbourne, VIC, AUS, 3004
Website
https://respiri.co
Respiri Ltd is a company engaged in the research, development, and commercialization of medical devices and the production of mobile health applications for the management of asthma and related chronic respiratory diseases. It operates through the following segments: The Australia segment includes research, development, and commercialisation of medical devices, and the production of mobile health applications in Australia. The company generates revenue through Medical Devices Segment in Australia.

Respiri (ASX:RSH) Headlines

No Headlines